Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Botulism

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

Tetanus

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Psychogenic (Functional) Movement Disorders.

Continuum (Minneapolis, Minn.)·2019

Same author

Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.

Parkinsonism & related disorders·2019

Same author

Young-onset Parkinson's disease: Its unique features and their impact on quality of life.

Parkinsonism & related disorders·2019

Same author

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?

Frontiers in neurology·2019

Same author

Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.

Journal of the neurological sciences·2019

Same author

Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).

Molecular genetics & genomic medicine·2019

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

Disease-oriented approach to botulinum toxin use.

Joseph Jankovic¹

¹Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, TX 77030, USA. josephj@bcm.edu

Toxicon : Official Journal of the International Society on Toxinology

|December 17, 2008

Summary

This summary is machine-generated.

Botulinum toxin (BoNT) offers diverse therapeutic benefits for Parkinson's disease (PD) symptoms. This review details BoNT's applications in treating conditions like dystonia, tremor, sialorrhea, and constipation associated with PD.

More Related Videos

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

Related Experiment Videos

Last Updated: Jun 27, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

Area of Science:

Neurology
Pharmacology
Medical Therapeutics

Background:

Botulinum toxin (BoNT) has a long history of treating over 100 conditions.
Many BoNT-indicated symptoms are prevalent in neurological disorders.
Parkinson's disease (PD) is a neurodegenerative disorder where BoNT is extensively used.

Purpose of the Study:

To review the therapeutic applications of Botulinum toxin (BoNT) in conditions associated with Parkinson's disease (PD).

Main Methods:

Literature review of studies on Botulinum toxin (BoNT) use in Parkinson's disease (PD).

Main Results:

BoNT is effective for various PD-associated symptoms including limb dystonia, blepharospasm, bruxism, cervical dystonia, camptocormia, tremor, rigidity, freezing of gait, sialorrhea, dysphagia, seborrhea, hyperhidrosis, overactive bladder, and constipation.

Conclusions:

Botulinum toxin (BoNT) is a versatile therapeutic agent for managing a wide spectrum of symptoms in Parkinson's disease (PD).
Further research may explore novel applications and optimize existing treatments.